{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:45:58Z","timestamp":1789019158596,"version":"build-2803163510"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,9,15]]},"DOI":"10.2169\/internalmedicine.2402-18","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T18:03:28Z","timestamp":1559844208000},"page":"2689-2693","source":"Crossref","is-referenced-by-count":5,"title":["An Anti-PM\/Scl-75 Antibody-positive Japanese Woman Who Developed Inflammatory Myopathy"],"prefix":"10.2169","volume":"58","author":[{"given":"Yuki","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Neurology, Sapporo Kosei General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Miyanaga","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Kosei General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Shizukawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Kosei General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Shimohama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wolfe JF, Adelstein E, Sharp GC. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest 59: 176-178, 1977.","DOI":"10.1172\/JCI108616"},{"key":"2","unstructured":"2. D'Aoust J, Hudson M, Tatibouet S, et al. Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheumatol 66: 1608-1615, 2014."},{"key":"3","unstructured":"3. Kohara A, Yanaba K, Muro Y, et al. Anti-PM\/Scl antibody-positive dermatomyositis in a Japanese patient: a case report and review of the literature. Int J Rheum 20: 2186-2189, 2017."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Muro Y, Hosono Y, Sugiura K, Ogawa Y, Mimori T, Akiyama M. Anti-PM\/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma. Arthritis Res Ther 17: 57, 2015.","DOI":"10.1186\/s13075-015-0573-x"},{"key":"5","unstructured":"5. Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76: 1955-1964, 2017."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. De Lorenzo R, Pinal-Fernandez I, Huang W, et al. Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies. Nsurology 90: e2068-e2076, 2018.","DOI":"10.1212\/WNL.0000000000005638"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 35: 449-456, 1992.","DOI":"10.1002\/art.1780350415"},{"key":"8","unstructured":"8. Kaji K, Fertig N, Medsger TA Jr, et al. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Arthritis Care Res (Hoboken) 66: 575-584, 2014."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, et al. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 40: 1257-1266, 1997.","DOI":"10.1002\/art.10"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Reichlin M, Maddison PJ, Targoff I, et al. Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol 4: 40-44, 1984.","DOI":"10.1007\/BF00915286"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Brouwer R, Hengstman GJ, Vree Egberts W, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60: 116-123, 2001.","DOI":"10.1136\/ard.60.2.116"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Mart\u00ednez-G\u00f3mez X, Vilardell-Tarr\u00e9s M. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55: 791-798, 2006.","DOI":"10.1002\/art.22237"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mahler M, Raijmakers R, D\u00e4hnrich C, Bl\u00fcthner M, Fritzler MJ. Clinical evaluation of autoantibodies to a novel PM\/Scl peptide antigen. Arthritis Res Ther 7: R704-R713, 2005.","DOI":"10.1186\/ar1729"},{"key":"14","unstructured":"14. Rozman B, Cucnik S, Sodin-Semrl S, et al. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study. Ann Rheum Dis 67: 1282-1286, 2008."},{"key":"15","unstructured":"15. Vandergheynst F, Ocmant A, Sordet C, et al. Anti-pm\/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin Exp Rheumatol 24: 129-133, 2006."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Marie I, Lahaxe L, Benveniste O, et al. Long-term outcome of patients with polymyositis\/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol 162: 337-344, 2010.","DOI":"10.1111\/j.1365-2133.2009.09484.x"},{"key":"17","unstructured":"17. Fernandez C, Bardin N, De Paula AM, et al. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis. Medicine (Baltimore) 92: 15-24, 2013."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Paik JJ, Wigley FM, Lloyd TE, et al. Spectrum of muscle histopathologic findings in forty-two scleroderma patients with weakness. Arthritis Care Res (Hoboken) 67: 1416-1425, 2016.","DOI":"10.1002\/acr.22620"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/18\/58_2402-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T23:38:28Z","timestamp":1569022708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/18\/58_2402-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,15]]},"references-count":18,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2402-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,15]]}}}